Petra Acquisition (PAIC) Short Interest Ratio & Short Volume

Short interest is the volume of Petra Acquisition shares that have been sold short but have not yet been closed out or covered. As of December 15th, traders have sold 900 shares of PAIC short. 0.01% of Petra Acquisition's shares are currently sold short. Learn More on Petra Acquisition's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.01% of Petra Acquisition's floating shares are currently sold short.

Petra Acquisition saw a decrease in short interest during the month of December. As of December 15th, there was short interest totaling 900 shares, a decrease of 67.9% from the previous total of 2,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Petra Acquisition currently has issued a total of 9,098,000 shares. Some of Petra Acquisition's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Petra Acquisition currently has a public float of 6,530,000 shares.

0.01% of Petra Acquisition's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Petra Acquisition: Journey Medical Co. (2.48%), Assertio Holdings, Inc. (10.93%), Anebulo Pharmaceuticals, Inc. (0.20%), Leap Therapeutics, Inc. (4.87%), SELLAS Life Sciences Group, Inc. (9.37%), Tempest Therapeutics, Inc. (6.09%), InflaRx (0.66%), MediciNova, Inc. (0.72%), Cue Biopharma, Inc. (8.63%), Spero Therapeutics, Inc. (1.21%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($10.20 billion), S&P Global Inc. ($9.27 billion), Canadian Pacific Kansas City Limited ($8.89 billion), Charter Communications, Inc. ($4.91 billion), Palo Alto Networks, Inc. ($3.82 billion), Wayfair Inc. ($3.47 billion), Lucid Group, Inc. ($3.06 billion), Zscaler, Inc. ($2.54 billion), Teladoc Health, Inc. ($2.27 billion), and Datadog, Inc. ($2.24 billion). View all of the most shorted stocks.

Short selling PAIC is an investing strategy that aims to generate trading profit from Petra Acquisition as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Petra Acquisition occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PAIC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PAIC, twice per month. The most recent reporting period available is December, 15 2021.